Core Scientific Statistics
Total Valuation
Core Scientific has a market cap or net worth of 4.10 billion. The enterprise value is 4.59 billion.
| Market Cap | 4.10B |
| Enterprise Value | 4.59B |
Important Dates
The next estimated earnings date is Monday, August 4, 2025.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -19.45% |
| Shares Change (QoQ) | +18.67% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 288.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 15.08 |
| PS Ratio | 9.97 |
| PB Ratio | -22.58 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.22 |
| EV / Sales | 11.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -26.81 |
Financial Position
The company has a current ratio of 4.26
| Current Ratio | 4.26 |
| Quick Ratio | 3.58 |
| Debt / Equity | n/a |
| Debt / EBITDA | 324.50 |
| Debt / FCF | -6.97 |
| Interest Coverage | -5.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -6.09% |
| Return on Invested Capital (ROIC) | -11.00% |
| Return on Capital Employed (ROCE) | -8.31% |
| Revenue Per Employee | 1.26M |
| Profits Per Employee | -2.71M |
| Employee Count | 325 |
| Asset Turnover | 0.34 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Core Scientific has paid 858,000 in taxes.
| Income Tax | 858,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.27 |
| Relative Strength Index (RSI) | 47.46 |
| Average Volume (20 Days) | 187,007 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.01 |
Income Statement
In the last 12 months, Core Scientific had revenue of 410.91 million and -879.79 million in losses. Loss per share was -3.20.
| Revenue | 410.91M |
| Gross Profit | 63.87M |
| Operating Income | -118.84M |
| Pretax Income | -944.15M |
| Net Income | -879.79M |
| EBITDA | -14.90M |
| EBIT | -118.84M |
| Loss Per Share | -3.20 |
Balance Sheet
The company has 697.94 million in cash and 1.19 billion in debt, giving a net cash position of -496.21 million.
| Cash & Cash Equivalents | 697.94M |
| Total Debt | 1.19B |
| Net Cash | -496.21M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -181.51M |
| Book Value Per Share | -0.61 |
| Working Capital | 637.67M |
Cash Flow
In the last 12 months, operating cash flow was -19.88 million and capital expenditures -151.49 million, giving a free cash flow of -171.37 million.
| Operating Cash Flow | -19.88M |
| Capital Expenditures | -151.49M |
| Free Cash Flow | -171.37M |
| FCF Per Share | n/a |
Margins
Gross margin is 15.54%, with operating and profit margins of -28.92% and -229.98%.
| Gross Margin | 15.54% |
| Operating Margin | -28.92% |
| Pretax Margin | -229.77% |
| Profit Margin | -229.98% |
| EBITDA Margin | -3.63% |
| EBIT Margin | -28.92% |
| FCF Margin | n/a |
Dividends & Yields
Core Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 19.45% |
| Shareholder Yield | n/a |
| Earnings Yield | -21.47% |
| FCF Yield | -4.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Core Scientific has an Altman Z-Score of -1.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.36 |
| Piotroski F-Score | 2 |